FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
  1. Home
  2. APOLLOHOSP Forum

APOLLOHOSP

4,562 -169.8 (-3.59%)
Updated 03:29 27/09 IST
90% Bullish
10% Bearish
15 Users have submitted 20 trade ideas of Rs. 2,932,991.24 for APOLLOHOSP
Disclaimer

Brokerage Reports

No. of reports in last year
3
No. of analysts
3
Average Consensus Forecast
3947.33
Consensus Potential
-21.31%
See APOLLOHOSP Share Price Targets >>

APOLLOHOSP Share Price Discussion

F
Reputation: 0 • Sep 24 4:15 AM

Type
Buy
Instrument
APOLLOHOSP
Entry Price
₹4,884.4
Price@Trade
₹4,910.85
Target Price
₹5,050
Stop Price
₹4,859.4
Valid Till
Oct 22, 2021 3:20 AM
Margin
₹97,688 approx for 20 Qty
Status
Waiting for entry
Like
Reply
swap_vert
Trade

Type
Buy
Instrument
APOLLOHOSP SEP21 FUT
Entry Price
₹4,947  ₹4,944
Price@Trade
₹4,946.2
Target Price
₹5,035
Stop Price
₹4,921
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹310,964.94 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹4,921
Net P&L
-₹5,750 (-1.85%)
Like
Reply (3)
swap_vert
Trade
See all replies

Update
Entry Price Modified
Price @ Update
₹4,944
Original Entry Price
₹4,947
New Entry Price
₹4,944
TrackerBot @trackerbot
Sep 24 3:56 AM

Update
Trade Entered
Entry Price
₹4,944
TrackerBot @trackerbot
Sep 24 4:02 AM

Update
Stoploss Hit
Exit Price
₹4,921

Type
Buy
Instrument
APOLLOHOSP SEP21 FUT
Entry Price
₹4,977.9
Price@Trade
₹4,977.9
Target Price
₹5,035
Stop Price
₹4,951
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹311,236.63 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹4,951
Net P&L
-₹6,725 (-2.16%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 3:54 AM

Update
Stoploss Hit
Exit Price
₹4,951

Type
Buy
Instrument
APOLLOHOSP SEP21 FUT
Entry Price
₹4,975
Price@Trade
₹4,972.65
Target Price
₹5,050
Stop Price
₹4,950
Valid Till
Sep 27, 2021 3:20 AM
Margin
₹622,356 approx for 500 Qty
Status
Exited
Exit Price
₹4,953.8
Net P&L
-₹10,600 (-1.7%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 3:51 AM

Update
Trade Entered
Entry Price
₹4,975
MD FAISAL @faisalahmad
Sep 24 3:53 AM

Update
Exited
Exit Price
₹4,953.8
Net P&L
-₹10,600 (-1.7%)

Type
Sell
Instrument
APOLLOHOSP SEP21 5000 CE
Entry Price
₹140
Price@Trade
₹139.05
Target Price
₹100
Stop Price
₹150
Valid Till
Sep 27, 2021 3:20 AM
Margin
₹673,174.38 approx for 500 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
MD FAISAL @faisalahmad
Sep 24 3:45 AM

Update
Exited before entry
Price @ Update
₹132

Type
Buy
Instrument
APOLLOHOSP
Entry Price
₹4,925
Price@Trade
₹4,956
Target Price
₹5,125
Stop Price
₹4,850
Valid Till
Sep 23, 2022 3:20 AM
Margin
₹49,250 approx for 10 Qty
Status
Active
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 4:02 AM

Update
Trade Entered
Entry Price
₹4,925

Type
Sell
Instrument
APOLLOHOSP SEP21 5100 CE
Entry Price
₹126
Price@Trade
₹126
Target Price
₹1
Stop Price
₹140
Valid Till
Sep 30, 2021 3:20 AM
Margin
₹312,934.56 approx for 250 Qty
Status
Exited
Exit Price
₹84.4
Net P&L
+₹10,400 (+3.32%)
Like
Reply (1)
swap_vert
Trade
See all replies
Manish Batra @mbatra
Sep 24 4:02 AM

Update
Exited
Exit Price
₹84.4
Net P&L
+₹10,400 (+3.32%)
P
Reputation: 0 • Sep 24 3:07 AM

Type
Buy
Instrument
APOLLOHOSP
Entry Price
₹4,991.05
Price@Trade
₹4,991.05
Target Price
₹5,100
Stop Price
₹4,850
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹499,105 approx for 100 Qty
Status
Exited
Exit Price
₹4,937
Net P&L
-₹5,405 (-1.08%)
Like
Reply (1)
swap_vert
Trade
See all replies
Pravesh @pk9984
Sep 24 3:55 AM

Update
Exited
Exit Price
₹4,937
Net P&L
-₹5,405 (-1.08%)

Type
Buy
Instrument
APOLLOHOSP
Entry Price
₹5,135
Price@Trade
₹5,036.05
Target Price
₹5,545
Stop Price
₹4,826
Valid Till
Oct 22, 2021 3:20 AM
Margin
₹148,915 approx for 29 Qty
Status
Waiting for entry
Like
Reply
swap_vert
Trade

Type
Buy
Instrument
APOLLOHOSP SEP21 5200 CE
Entry Price
₹127.2
Price@Trade
₹127.2
Target Price
₹166
Stop Price
₹100
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹31,800 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹100
Net P&L
-₹6,800 (-21.38%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 2:57 AM

Update
Stoploss Hit
Exit Price
₹100

Type
Buy
Instrument
APOLLOHOSP
Entry Price
₹5,085
Price@Trade
₹5,110
Target Price
₹5,200
Stop Price
₹5,060
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹5,085 approx for 1 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited before entry
Price @ Update
₹5,055.15

Type
Buy
Instrument
APOLLOHOSP SEP21 5200 CE
Entry Price
₹146
Price@Trade
₹129.95
Target Price
₹166
Stop Price
₹125
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹36,500 approx for 250 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies

Update
Exited before entry
Price @ Update
₹127.3

Type
Buy
Instrument
APOLLOHOSP SEP21 5200 CE
Entry Price
₹160
Price@Trade
₹125
Target Price
₹163
Stop Price
₹155
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹40,000 approx for 250 Qty
Status
Waiting for entry
Like
Reply
swap_vert
Trade
S
Reputation: 0 • Sep 24 2:50 AM

Type
Buy
Instrument
APOLLOHOSP SEP21 5150 CE
Entry Price
₹140
Price@Trade
₹145
Target Price
₹250
Stop Price
₹130
Valid Till
Sep 30, 2021 3:20 AM
Margin
₹35,000 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹130
Net P&L
-₹2,500 (-7.14%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 2:51 AM

Update
Trade Entered
Entry Price
₹140
TrackerBot @trackerbot
Sep 24 2:56 AM

Update
Stoploss Hit
Exit Price
₹130

Type
Buy
Instrument
APOLLOHOSP SEP21 FUT
Entry Price
₹5,170  ₹5,169.3
Price@Trade
₹5,178.15
Target Price
₹5,300
Stop Price
₹5,125
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹312,734.19 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹5,125
Net P&L
-₹11,075 (-3.54%)
Like
Reply (3)
swap_vert
Trade
See all replies

Update
Entry Price Modified
Price @ Update
₹5,169.3
Original Entry Price
₹5,170
New Entry Price
₹5,169.3
TrackerBot @trackerbot
Sep 24 2:47 AM

Update
Trade Entered
Entry Price
₹5,169.3
TrackerBot @trackerbot
Sep 24 2:51 AM

Update
Stoploss Hit
Exit Price
₹5,125
M
Reputation: 0 • Sep 24 2:45 AM

Type
Buy
Instrument
APOLLOHOSP SEP21 5150 CE
Entry Price
₹159
Price@Trade
₹159
Target Price
₹200
Stop Price
₹146
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹39,750 approx for 250 Qty
Status
Stoploss Hit
Exit Price
₹146
Net P&L
-₹3,250 (-8.18%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 2:51 AM

Update
Stoploss Hit
Exit Price
₹146

Apollo hospital very good breakout of one month consolidation
ready for 500-1000 points rally....
APOLLOHOSP - chart - 4837459
Like
Reply

Type
Buy
Instrument
APOLLOHOSP SEP21 FUT
Entry Price
₹5,142
Price@Trade
₹5,139.9
Target Price
₹5,200
Stop Price
₹5,060
Valid Till
Sep 24, 2021 3:20 AM
Margin
₹305,273 approx for 250 Qty
Status
Target Achieved
Exit Price
₹5,200
Net P&L
+₹14,500 (+4.75%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 23 9:00 AM

Update
Trade Entered
Entry Price
₹5,142
TrackerBot @trackerbot
Sep 24 2:46 AM

Update
Target Achieved
Exit Price
₹5,200

Type
Buy
Instrument
APOLLOHOSP SEP21 5100 CE
Entry Price
₹171
Price@Trade
₹171
Target Price
₹200
Stop Price
₹100
Valid Till
Sep 30, 2021 3:20 AM
Margin
₹42,750 approx for 250 Qty
Status
Target Achieved
Exit Price
₹200
Net P&L
+₹7,250 (+16.96%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 24 2:47 AM

Update
Target Achieved
Exit Price
₹200

Type
Buy
Instrument
APOLLOHOSP SEP21 5100 CE
Entry Price
₹169
Price@Trade
₹167
Target Price
₹190
Stop Price
₹100
Valid Till
Sep 30, 2021 3:20 AM
Margin
₹42,250 approx for 250 Qty
Status
Target Achieved
Exit Price
₹190
Net P&L
+₹5,250 (+12.43%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Sep 23 8:59 AM

Update
Trade Entered
Entry Price
₹169
TrackerBot @trackerbot
Sep 24 2:46 AM

Update
Target Achieved
Exit Price
₹190

APOLLOHOSP Ratings

Long term APOLLOHOSP rating by FrontPage users
5/5 (3 Ratings)
Find answers to all your questions on live APOLLOHOSP message board: Is APOLLOHOSP buy or sell? Should I buy APOLLOHOSP shares? Why are APOLLOHOSP shares falling? Should I invest in APOLLOHOSP stock?

Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • APOLLOHOSP - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization16,985.86
    Enterprise Value19,761.2
    Price to Earnings63.45
    Price to Book Value4.37
    Return on Capital Employed0.09
    Return on Equity0.06
    Face Value5
    Dividend YieldNA
  • APOLLOHOSP - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    20-Aug-21Geojit Financial ServicesReduce4,042
    16-Aug-21HDFC SecuritiesAdd4,410
    19-Apr-21EdelweissBuy3,390
    10-Dec-19ICICIdirect.comBuy1,800
    26-Jun-19Indiabulls VenturesBuy1,580
    APOLLOHOSP Brokerage Price Target
  • APOLLOHOSP Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 274748.847714464.14565.55
    Sep 245156.151984711.554731.8
    Sep 234931.4513449055084.2
    Sep 22492550104869.94904.9
    Sep 2148584918.954790.154891.6
  • APOLLOHOSP Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹4,867.16
    30 Day Moving Average₹4,800.95
    50 Day Moving Average₹4,482.33
    100 Day Moving Average₹3,927.48
    200 Day Moving Average₹3,359.8
  • APOLLOHOSP - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7,1836,441.770.12
    Operating Profit830774.010.07
    Profit Before Tax330358.92-0.08
    Net Income233285.15-0.18
  • APOLLOHOSP - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,8843,6940.05
    Total Liabilities4,5454,688-0.03
    Total Assets8,4288,3820.01
  • APOLLOHOSP - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity539623.51-0.14
    Cash from Investing Activity-378-817.62-0.54
    Cash from Financing Activity-106211.16-1.5
    Net Cash Flow5417.052.17
  • APOLLOHOSP - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.04
    Return on Equity0.060.08
    Return on Capital Employed0.090.09
  • APOLLOHOSP - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.56
    3 Year CAGR Growth in Operating Profit0.25
    3 Year CAGR Growth in EBIDTA0.19
    3 Year CAGR Growth in Net Income-0.33
    3 Yr CAGR Growth - Diluted EPS-0.33
  • APOLLOHOSP - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.16
    5 Year CAGR Growth in Operating Profit0.5
    5 Year CAGR Growth in EBIDTA0.43
    5 Year CAGR Growth in Net Income-0.25
    3 Yr CAGR Growth - Diluted EPS-0.25
  • APOLLOHOSP - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 6 2:36 AM
    Apollo hospital unit claims completion of 100 robotic cardiac surgeries
    The Economic Times
    NewsBot
    Sep 6 11:16 AM
    Jio completes five years of operations; tech world congratulates
    The Economic Times
    NewsBot
    Aug 29 3:01 AM
    Three hospital chains to raise up top Rs 6,300 crore via IPOs
    The Economic Times
    NewsBot
    Aug 26 5:41 AM
    Devang Mehta on how to build a taper-proof portfolio
    The Economic Times
    NewsBot
    Aug 25 5:36 AM
    Sandip Sabharwal on why Bajaj Finance, Fortis valuations are unsustainable
    The Economic Times
    NewsBot
    Aug 22 6:46 AM
    The week that was in 10 stocks: VST Tillers zooms 40%, Ujjivan SFB bleeds
    The Economic Times
    NewsBot
    Aug 18 2:51 AM
    Why Tech Mahindra is emerging as a dark horse: Chakri Lokapriya
    The Economic Times
    NewsBot
    Aug 17 10:01 AM
    Biggest gainers & losers of the day: Hospital stocks roar; Vedanta bleeds
    The Economic Times
    NewsBot
    Aug 17 2:56 AM
    Expect robust earnings from steel cos in next 2 quarters: Anand Tandon
    The Economic Times
    NewsBot
    Aug 16 12:56 PM
    Stocks in the news: Devyani Intl, Windlas Bio, ONGC, VIL, JK Cement and Exxaro
    The Economic Times
  • APOLLOHOSP - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
    Piramal Enterprises Ltd. NSE: PEL | B...
  • APOLLOHOSP - More Information

    keyboard_arrow_down

    Apollo Hospitals Enterprises Ltd:
    Along with its subsidiaries, Apollo Hospitals Enterprise Limited has been providing healthcare services in India with an international venture. Primary, Secondary, and Tertiary care facilities are comprised of the company. Including cardiac sciences, oncology, critical care, neurosciences, orthopaedics, gastroenterology, and transplants tertiary care hospitals provide care in around 55 specialities. Along with this, the firm is providing different services, including project consultancy, health insurance, education and training program, and research services. Besides that pharmacies, primary care clinics, birthing centres, single-speciality clinics, primary health centres and diagnostic chains, dental clinics, and day-care and home healthcare centres operated by the firm. As of January 2019, the company started running 71 hospitals possessing 10,000 beds; 3,000 pharmacies. The company has 90 primary care and diagnostic clinics and approximately 110 telemedicine centres. Apollo Hospitals Enterprise Limited incepted in 1979 and has it headquarter in Chennai, India.
    Company Information:
    The company, seven years after its inception, added 46 beds in 1985. This group introduced the idea of developing corporate healthcare in India for the first time. Apollo introduced such hospitals which were providing the facility of Magnetic Resonance Imaging (MRI) even in the year of 1989, along with SOMATOMCR which is a Computed Tomography scanner for the entire body; Breast-scanning equipment such as Dideoendoscopy and Mammography were introduced too.
    In August 1991 The Apollo School of Nursing was founded, offering a 3-year diploma programme with an internship in the hospital. The hospital added 16 intensive care beds in 1992, along with developing its equipment in different departments. In 1993, Apollo Cancer Hospital, a premium cancer treatment and research centre, was established with 150-beds in Chennai. Along with that, it introduced the bone marrow transplant facility, developing its cancer project.
    Apollo Hospital Enterprise Limited (AHEL), developed a cancer hospital again in Hyderabad in 1995. In the same year, it was joined in the mission of eradicating Tuberculosis in India under WHO.
    Signing an MOU with Jardine of UK, AHEL adopted the health maintenance organisations (HMO) in 1997, a concept the nation witnessed for the first time. In the next year 1998, an MOU was signed between AHEL and Sri Lankan Government for building a super-speciality hospital in Colombo, which opened the door of AHEL’s international intervention.
    In 2002, the hospital captured the 50.26 % of in the Duncan Gleneagles Hospital against a minimal amount of Rs.3 crore. A tie-up with ICICI Lombard took place in 2003, introducing an accident insurance product. Developing a technology partnership with the Defence Research & Development Organisation (DRDO), AHEL enhanced its strength in 2004.
    Apollo Hospital Delhi was awarded a JCI certificate in 2005 for providing care in a safe environment. In June 2007, AHEL introduced Health City, for the first time in Asia, at Hyderabad with a holistic healthcare delivery facility, with an area of 33 acres mot only for treatment and research but also for hospitality management. In January 2008, an agreement took place between the hospital and the real estate firm Hindustan Construction Co (HCC), for launching a top-class medi-city inside the hill station Lavasa in Maharashtra.
    In June 2012, AHEL declared that International Finance Corporation (IFC) had requested the company for the transformation of the balance loan amount of US$ 7.50 million of Foreign Currency Convertible Bonds (FCCBs) into equity shares. Through making a primary equity infusion of Rs.450 crore, World Bank affiliated International Finance Corporation acquired a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a subsidiary of the company, in the year of December 2016.
    Net profit of the company enhanced 28.57% to Rs.76.68 crore in the first quarter of 2019, ending in March against that of the previous quarter ended on March 2018 with Rs.59.64 crore. Similarly, the sales are enhanced by 16.30% to Rs.2167.11 crore in the first quarter of 2019 compared to the sales amount of Rs.1863.42 crore, that the company acquired in the first quarter of 2018.
    How Apollo Hospitals Enterprises Ltd, is categorised as Healthcare Sector, and Hospitals and Medical services Industry :
    Hospital and Medical Services Industry includes companies that are engaged in offering healthcare medical services and also operating standalone pharmacies. They offer services like hospitals, hospital-based pharmacies, consultancy services and projects. Some companies also provide health insurance services, research services and education and training programs.
    Apollo Hospitals Enterprises Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Apollo Hospitals Enterprises Ltd, Competitors and Sector Peers:
    ADS Diagnostic Ltd. ADSDIA
    ANG Lifesciences India Ltd. ANGLIF
    Artemis Global Life Sciences Ltd. ARTGLO
    Aspira Pathlab & Diagnostics Ltd. ASPPAT
    Aster DM Healthcare Ltd. ASTDMH
    Birla Pacific Medspa Ltd. BIRPAC
    CDR Health Care Ltd. CDRHEA
    Chennai Meenakshi Multispeciality Hospital Ltd. DEVHOS
    Deccan Health Care Ltd. DECHEA
    Dhanvantri Jeevan Rekha Ltd. DHAJEE
    Dolphin Medical Services Ltd. DOLMED
    Dr. Agarwal's Eye Hospital Ltd. DRAGA
    Dr. Lal Pathlabs Ltd. DRLAL
    Dr. Lalchandani Labs Ltd. DRLALL
    Fortis Healthcare Ltd. FORHEA
    Fortis Malar Hospitals Ltd. MALHOS
    Healthcare Global Enterprises Ltd. HEAGLO
    Indo-Global Enterprises Ltd. INDOE
    Indraprastha Medical Corporation Ltd. INDRME
    Kids Medical Systems Ltd. KIDMED
    KMC Speciality Hospitals (India) Ltd. SEAHOS
    Kovai Medical Center and Hospital Ltd. KOVMED
    Looks Health Services Ltd. MONHEA
    Lotus Eye Hospital and Institute Ltd. LOTEYE
    Medinova Diagnostic Services Ltd. MEDDIA
    Metropolis Healthcare Ltd. METHEA
    N G Industries Ltd. NGINDL
    Narayana Hrudayalaya Ltd. NARHRU
    Noida Medicare Centre Ltd. NOIMED
    Regency Hospitals Ltd. REGHOS
    Sakar Healthcare Ltd. SAKHEA
    Scandent Imaging Ltd. PHACOM
    Secunderabad Healthcare Ltd. SECHEA
    Shalby Ltd. SHALLT
    Soni Medicare Ltd. SONMED
    STG Lifecare Ltd. STGTEC
    Tejnaksh Healthcare Ltd. TEJHEA
    Thyrocare Technologies Ltd. THYTEC
    Vimta Labs Ltd. VIMLAB
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.